Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol (Q37465379)
Jump to navigation
Jump to search
scientific article published on 13 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol |
scientific article published on 13 August 2013 |
Statements
1 reference
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol (English)
1 reference
D van der Heijde
1 reference
R Fleischmann
1 reference
J Wollenhaupt
1 reference
A Deodhar
1 reference
D Kielar
1 reference
F Woltering
1 reference
C Stach
1 reference
B Hoepken
1 reference
T Arledge
1 reference
P J Mease
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference